| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human α-synuclein A30P+A53T transgenic mice
|
Ono, Kazuhiko
|
|
2009
|
15 |
Supplement 4 |
p. 649-654
6 p.
|
artikel
|
| 2 |
Announcement
|
|
|
2009
|
15 |
Supplement 4 |
p. 482-
1 p.
|
artikel
|
| 3 |
Avances en tratamiento medico de la enfermedad de Parkinson [Advances in the medical treatment of Parkinson's disease]
|
Chaná, Pedro
|
|
2009
|
15 |
Supplement 4 |
p. S22-S25
4 p.
|
artikel
|
| 4 |
Clinimetric analyses of the Modified Parkinson Activity Scale
|
Keus, S.H.J.
|
|
2009
|
15 |
Supplement 4 |
p. 263-269
7 p.
|
artikel
|
| 5 |
Compound heterozygosity in DJ-1 gene non-coding portion related to parkinsonism
|
Tarantino, Patrizia
|
|
2009
|
15 |
Supplement 4 |
p. 324-326
3 p.
|
artikel
|
| 6 |
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
|
Kalaitzakis, M.E.
|
|
2009
|
15 |
Supplement 4 |
p. 196-204
9 p.
|
artikel
|
| 7 |
Does melatonin help save dopaminergic cells in MPTP-treated mice?
|
Ma, Jeannine
|
|
2009
|
15 |
Supplement 4 |
p. 307-314
8 p.
|
artikel
|
| 8 |
Dopamine receptor agonists and sleep disturbances in Parkinson's disease
|
Chaudhuri, K. Ray
|
|
2009
|
15 |
Supplement 4 |
p. S101-S104
4 p.
|
artikel
|
| 9 |
Excessive daytime sleepiness in cervical dystonia
|
Trotti, Lynn Marie
|
|
2009
|
15 |
Supplement 4 |
p. 784-786
3 p.
|
artikel
|
| 10 |
Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes
|
Hasegawa, Kazuko
|
|
2009
|
15 |
Supplement 4 |
p. 300-306
7 p.
|
artikel
|
| 11 |
Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics
|
Ross, Christopher A.
|
|
2009
|
15 |
Supplement 4 |
p. S135-S138
4 p.
|
artikel
|
| 12 |
Iron transport in Parkinson's disease
|
Hirsch, E.C.
|
|
2009
|
15 |
Supplement 4 |
p. S209-S211
3 p.
|
artikel
|
| 13 |
Levodopa therapeutics for Parkinson's disease: new developments
|
LeWitt, Peter A.
|
|
2009
|
15 |
Supplement 4 |
p. S31-S34
4 p.
|
artikel
|
| 14 |
Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys
|
Grégoire, Laurent
|
|
2009
|
15 |
Supplement 4 |
p. 445-452
8 p.
|
artikel
|
| 15 |
Mild cognitive impairment in Parkinson's disease
|
Adler, Charles H.
|
|
2009
|
15 |
Supplement 4 |
p. S81-S82
2 p.
|
artikel
|
| 16 |
Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease
|
Bardien, Soraya
|
|
2009
|
15 |
Supplement 4 |
p. 116-121
6 p.
|
artikel
|
| 17 |
Motor overflow and mirror dystonia
|
Sitburana, Oraporn
|
|
2009
|
15 |
Supplement 4 |
p. 758-761
4 p.
|
artikel
|
| 18 |
Neuroinflammation in the living brain of Parkinson's disease
|
Ouchi, Yasuomi
|
|
2009
|
15 |
Supplement 4 |
p. S200-S204
5 p.
|
artikel
|
| 19 |
O.059 Are growth factors the answer in Parkinson's disease?
|
Barker, R.
|
|
2009
|
15 |
Supplement 4 |
p. S15-S16
2 p.
|
artikel
|
| 20 |
Octarepeat changes of prion protein in Parkinson's disease
|
Wang, Vinchi
|
|
2009
|
15 |
Supplement 4 |
p. 53-58
6 p.
|
artikel
|
| 21 |
O.073 Current understanding of myoclonus
|
Caviness, J.
|
|
2009
|
15 |
Supplement 4 |
p. S19-
1 p.
|
artikel
|
| 22 |
O.045 Mechanisms of dystonia
|
Standaert, D.
|
|
2009
|
15 |
Supplement 4 |
p. S12-
1 p.
|
artikel
|
| 23 |
O.076 Medical management of early Parkinson's disease
|
Hauser, R.
|
|
2009
|
15 |
Supplement 4 |
p. S20-
1 p.
|
artikel
|
| 24 |
O.100 New targets for DBS: can DBS modulate non-motor symptoms?
|
Moro, E.
|
|
2009
|
15 |
Supplement 4 |
p. S26-
1 p.
|
artikel
|
| 25 |
O.011 Psychogenic movement disorders
|
Jankovic, J.
|
|
2009
|
15 |
Supplement 4 |
p. S4-
1 p.
|
artikel
|
| 26 |
O.028 The spectrum of clinical manifestations of basal ganglia disorders: a challenge for any new model
|
Obeso, J.
|
|
2009
|
15 |
Supplement 4 |
p. S8-
1 p.
|
artikel
|
| 27 |
O.086 Treatment of dysautonomia associated with Parkinson's disease
|
Jankovic, J.
|
|
2009
|
15 |
Supplement 4 |
p. S22-
1 p.
|
artikel
|
| 28 |
O.042 Ultrasound in sialorrhea treatment in Parkinson's patients
|
Truong, D.
|
|
2009
|
15 |
Supplement 4 |
p. S12-
1 p.
|
artikel
|
| 29 |
P2.213 Ab amyloid deposits are common in brains of non-demented PD patients
|
Gomperts, S.
|
|
2009
|
15 |
Supplement 4 |
p. S147-
1 p.
|
artikel
|
| 30 |
P3.144 Acute L-DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of Parkinsonian rats
|
Szkilnik, R.
|
|
2009
|
15 |
Supplement 4 |
p. S185-
1 p.
|
artikel
|
| 31 |
P2.118 Allosteric modulation of group III metabotropic glutamate receptor 4: a potential neuroprotective approach for the treatment of Parkinson's disease
|
Betts, M.
|
|
2009
|
15 |
Supplement 4 |
p. S121-
1 p.
|
artikel
|
| 32 |
P2.004 Amygdala stimulation is not able to rescues the long-term potentiation (LTP) at the depotentiation synapses in the dentate gyrus
|
Duany, C.
|
|
2009
|
15 |
Supplement 4 |
p. S89-
1 p.
|
artikel
|
| 33 |
P2.151 Anticholinergics for axial symptoms in Parkinson's disease with subthalamic nucleus stimulation
|
Onozawa, R.
|
|
2009
|
15 |
Supplement 4 |
p. S130-
1 p.
|
artikel
|
| 34 |
P1.010 A proactive approach to falls in Parkinson's disease
|
Grantier, L.L.
|
|
2009
|
15 |
Supplement 4 |
p. S31-
1 p.
|
artikel
|
| 35 |
P1.082 A retrospective assessment of physical, cognitive, and affective factors that relate to falls in individuals with Parkinson's disease
|
Masterson, M.
|
|
2009
|
15 |
Supplement 4 |
p. S50-
1 p.
|
artikel
|
| 36 |
Parkin gene therapy
|
Mochizuki, Hideki
|
|
2009
|
15 |
Supplement 4 |
p. S43-S45
3 p.
|
artikel
|
| 37 |
P1.216 Arytenoid tremor predicts severity of glottic stenosis in multiple system atrophy
|
Ozawa, T.
|
|
2009
|
15 |
Supplement 4 |
p. S84-S85
2 p.
|
artikel
|
| 38 |
P2.021 Astrocytes: central role in Parkinson's pathology?
|
Schmidt, S.
|
|
2009
|
15 |
Supplement 4 |
p. S93-S94
2 p.
|
artikel
|
| 39 |
P1.161 Axial symptoms and basal ganglia in Parkinson's disease. Does side matter?
|
Sarwar, A.
|
|
2009
|
15 |
Supplement 4 |
p. S70-
1 p.
|
artikel
|
| 40 |
P1.113 Brain monoamine systems in multiple system atrophy: a positron emission tomography study
|
Pavese, N.
|
|
2009
|
15 |
Supplement 4 |
p. S58-
1 p.
|
artikel
|
| 41 |
P3.058 Ceruloplasmin is involved in the nigral iron accumulation of 6-OHDA lesioned rats
|
Wang, J.
|
|
2009
|
15 |
Supplement 4 |
p. S163-
1 p.
|
artikel
|
| 42 |
P2.124 Changes in quality of life and nocturnal symptoms in sleep-impaired patients with advanced Parkinson's disease treated with ropinirole prolonged release
|
Martinez-Martin, P.
|
|
2009
|
15 |
Supplement 4 |
p. S123-
1 p.
|
artikel
|
| 43 |
P1.202 Changes of procedural learning in patients with Wilson disease
|
Wang, X.-P.
|
|
2009
|
15 |
Supplement 4 |
p. S81-
1 p.
|
artikel
|
| 44 |
P1.007 Charcot's contribution to the study of Tourette's syndrome
|
Teive, H.
|
|
2009
|
15 |
Supplement 4 |
p. S30-
1 p.
|
artikel
|
| 45 |
P1.099 Color discrimination impairment with patients with Parkinson's disease and their regional cerebral blood flow changes
|
Watanabe, M.
|
|
2009
|
15 |
Supplement 4 |
p. S54-
1 p.
|
artikel
|
| 46 |
P2.182 Coping and quality of life in Parkinson disease: the deep brain stimulation effect
|
Montel, S.
|
|
2009
|
15 |
Supplement 4 |
p. S139-
1 p.
|
artikel
|
| 47 |
P2.035 Deep brain stimulation effects on orthostatic regulations in patients with Parkinson's disease
|
Hou, J.G.
|
|
2009
|
15 |
Supplement 4 |
p. S97-S98
2 p.
|
artikel
|
| 48 |
P1.175 Deflning a test score for status assessment during motor fluctuations in Parkinson's disease
|
Westin, J.
|
|
2009
|
15 |
Supplement 4 |
p. S74-
1 p.
|
artikel
|
| 49 |
P3.106 Dendritic cell vaccine against human a-synuclein aggregates
|
Cao, C.
|
|
2009
|
15 |
Supplement 4 |
p. S175-
1 p.
|
artikel
|
| 50 |
P1.144 Different effects between acupuncture and anti-parkinsonian medicine on the cortical excitability in patients with Parkinson's disease
|
Lin, Y.C.
|
|
2009
|
15 |
Supplement 4 |
p. S65-S66
2 p.
|
artikel
|
| 51 |
P3.178 Does quetiapine improve REM sleep behavior disorder (RBD) in Parkinson's disease? 3 case reports
|
Carvalho, D.
|
|
2009
|
15 |
Supplement 4 |
p. S194-
1 p.
|
artikel
|
| 52 |
P2.165 Dose-related decrease in “off” time with ropinirole prolonged release in patients with advanced Parkinson's disease
|
Stocchi, F.
|
|
2009
|
15 |
Supplement 4 |
p. S134-S135
2 p.
|
artikel
|
| 53 |
P3.192 Effect of bilateral globus pallidus internus deep brain stimulation on periodic limb movements in Parkinson's disease patient and possible mechanism
|
Lyons, M.
|
|
2009
|
15 |
Supplement 4 |
p. S197-
1 p.
|
artikel
|
| 54 |
P3.161 Effect of physical rehabilitation on perceived quality of life of persons with Parkinson disease
|
Dobi, D.
|
|
2009
|
15 |
Supplement 4 |
p. S189-
1 p.
|
artikel
|
| 55 |
Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity
|
Chou, Kelvin L.
|
|
2009
|
15 |
Supplement 4 |
p. 640-643
4 p.
|
artikel
|
| 56 |
P2.110 Evidence for association of high-dose levodopa therapy with intellectual and psychiatric complications of Parkinson's disease
|
Hamza, T.
|
|
2009
|
15 |
Supplement 4 |
p. S119-
1 p.
|
artikel
|
| 57 |
P2.096 Exendin-4 potentiates L-DOPA-evoked DA release in rat striatum
|
Abuirmeileh, A.
|
|
2009
|
15 |
Supplement 4 |
p. S114-S115
2 p.
|
artikel
|
| 58 |
P2.154 Exendin-4 promotes recovery of both behavioral and neurochemical deflcits in a “pre-motor” rodent model of Parkinson's disease
|
Rampersaud, N.
|
|
2009
|
15 |
Supplement 4 |
p. S131-
1 p.
|
artikel
|
| 59 |
P1.041 Factor structure of the Geriatric Depression Scale in Turkish Parkinson's disease patients
|
Ertan, T.
|
|
2009
|
15 |
Supplement 4 |
p. S39-
1 p.
|
artikel
|
| 60 |
P2.014 Gait analysis in a porcine model of progressive Parkinson disease established by chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication
|
Mogensen, P.
|
|
2009
|
15 |
Supplement 4 |
p. S91-S92
2 p.
|
artikel
|
| 61 |
P3.134 Infectious causes of parkinsonism
|
Munhoz, R.
|
|
2009
|
15 |
Supplement 4 |
p. S182-
1 p.
|
artikel
|
| 62 |
P1.058 Intracranial granulomas presenting as extrapyramidal disorder: a report of three cases
|
Jha, S.
|
|
2009
|
15 |
Supplement 4 |
p. S43-S44
2 p.
|
artikel
|
| 63 |
P1.110 123I-/V-cu-fluoro-propyl-2β-carbomethoxy-3β-(4-iodophenyl) nortropane ([123I] FP-CIT) SPECT in cases of multiple system atrophy
|
Gontu, V.
|
|
2009
|
15 |
Supplement 4 |
p. S57-
1 p.
|
artikel
|
| 64 |
P3.041 LINGO1 variant increases risk of familial essential tremor
|
Prakash, K.M.
|
|
2009
|
15 |
Supplement 4 |
p. S158-
1 p.
|
artikel
|
| 65 |
P2.076 MANF: a new potential disease-modifying drug candidate for Parkinson's disease
|
Commissiong, J.
|
|
2009
|
15 |
Supplement 4 |
p. S109-
1 p.
|
artikel
|
| 66 |
P1.072 Mapping motor and somatosensory cortical flnger representation in focal hand dystonia
|
Weise, D.
|
|
2009
|
15 |
Supplement 4 |
p. S47-
1 p.
|
artikel
|
| 67 |
P3.089 Microglial MAC1 and PI3K are essential in mediating beta-amyloid peptide-induced neurotoxicity in neuron/glia cultures
|
Zhang, D.
|
|
2009
|
15 |
Supplement 4 |
p. S171-
1 p.
|
artikel
|
| 68 |
P3.072 Mitochondrial NAD(H) suppliers rate-limit energy, signal transduction and redox-gradient spatio-temporal variables important for development and degeneration: lessons from Pellagra
|
Williams, A.C.
|
|
2009
|
15 |
Supplement 4 |
p. S167-
1 p.
|
artikel
|
| 69 |
P2.062 MLPA analysis in EOP patients
|
Barzaghi, C.
|
|
2009
|
15 |
Supplement 4 |
p. S105-
1 p.
|
artikel
|
| 70 |
P3.147 Neurodegenerative markers in CSF in patients suffering from Parkinson's disease
|
Vranová, H.
|
|
2009
|
15 |
Supplement 4 |
p. S186-
1 p.
|
artikel
|
| 71 |
P2.008 Neuroprotective effect of GLP-1R agonist exendin-4 in rat model of Parkinson's disease involves D3-receptor mediated changes in neural precursor cells
|
Harkavyi, A.
|
|
2009
|
15 |
Supplement 4 |
p. S90-
1 p.
|
artikel
|
| 72 |
P2.079 Neuroprotective properties of Poacynum against MPP+-toxicity to dopaminergic cells
|
Rausch, W.D.
|
|
2009
|
15 |
Supplement 4 |
p. S110-
1 p.
|
artikel
|
| 73 |
P1.055 Open-label naturalistic study of pregabalin for cervical dystonia and other hyperkinetic movement disorders (HMDs): effectiveness and tolerability
|
Chen, J.
|
|
2009
|
15 |
Supplement 4 |
p. S43-
1 p.
|
artikel
|
| 74 |
P1.127 Parkinson's disease subtypes and their relevance to studies of disease-modifying agents
|
Elm, J.
|
|
2009
|
15 |
Supplement 4 |
p. S61-
1 p.
|
artikel
|
| 75 |
P3.014 Pellagra: American epidemic of a curable, familial, neurodegenerative, immune-deflcient, metabolic and bioenergetic “redox” disorder. Tip of NAD(H) iceberg?
|
Williams, A.C.
|
|
2009
|
15 |
Supplement 4 |
p. S151-
1 p.
|
artikel
|
| 76 |
P3.017 Posterior alien hand phenomena as the flrst manifestation of HIV encephalopathy
|
Munhoz, R.
|
|
2009
|
15 |
Supplement 4 |
p. S152-
1 p.
|
artikel
|
| 77 |
P2.138 Prevalence and improvement of comprehensive (non-motor) symptom assessment after prolonged-release ropinirole (Requip XL)
|
Isaacson, J.
|
|
2009
|
15 |
Supplement 4 |
p. S127-
1 p.
|
artikel
|
| 78 |
P2.053 Primary Segmental Dystonia: 4 year follow-up of 11 patients treated with GPi deep brain stimulation
|
Sarubbo, S.
|
|
2009
|
15 |
Supplement 4 |
p. S102-S103
2 p.
|
artikel
|
| 79 |
P1.188 Psychogenic movement disorders – a Brazilian series of 72 cases
|
Helio, T.
|
|
2009
|
15 |
Supplement 4 |
p. S77-
1 p.
|
artikel
|
| 80 |
P2.141 Rasagiline provides symptomatic beneflt in early Parkinson's disease (PD)
|
Jankovic, J.
|
|
2009
|
15 |
Supplement 4 |
p. S127-S128
2 p.
|
artikel
|
| 81 |
P1.130 Rater training on UPDRS: assessing raters' ratings
|
Gaur, R.
|
|
2009
|
15 |
Supplement 4 |
p. S62-
1 p.
|
artikel
|
| 82 |
P2.018 Recapitulation of neurodegenerative disease and apoptotic neuronal cell death caused by 26S proteasome dysfunction
|
Rezvani, Z.N.
|
|
2009
|
15 |
Supplement 4 |
p. S92-S93
2 p.
|
artikel
|
| 83 |
P1.096 Selective frontal atrophy of the inferior fronto-occipital fasciculus in progressive supranuclear palsy (PSP)
|
Kvickström, P.
|
|
2009
|
15 |
Supplement 4 |
p. S53-
1 p.
|
artikel
|
| 84 |
P3.103 Serum iron levels are lower in Parkinson's disease patients as compared to controls and are modifled by haptoglobin phenotype
|
Costa-Mallen, P.
|
|
2009
|
15 |
Supplement 4 |
p. S174-
1 p.
|
artikel
|
| 85 |
P2.209 Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease
|
Raisman Vozari, R.
|
|
2009
|
15 |
Supplement 4 |
p. S146-
1 p.
|
artikel
|
| 86 |
P2.196 STN high frequency stimulation is effective in Parkinson's disease with camptocormia: a case report
|
Galazky, I.
|
|
2009
|
15 |
Supplement 4 |
p. S143-
1 p.
|
artikel
|
| 87 |
P2.093 Switch from subcutaneous apomorphine to intraduodenal levodopa offers additional beneflt on motor fluctuations and dyskinesias in advanced Parkinson's disease
|
Tamburin, S.
|
|
2009
|
15 |
Supplement 4 |
p. S114-
1 p.
|
artikel
|
| 88 |
P3.031 TaqI A polymorphism of dopamine D2 receptor gene (DRD2), dopamine dysregulation syndrome and impulse control disorders in Parkinson's disease
|
Gorzkowska, A.
|
|
2009
|
15 |
Supplement 4 |
p. S156-
1 p.
|
artikel
|
| 89 |
P2.199 The national deep brain stimulation brain tissue network (DBS-BTN): preliminary results
|
Vedam-Mai, V.
|
|
2009
|
15 |
Supplement 4 |
p. S143-S144
2 p.
|
artikel
|
| 90 |
P2.107 The protective effect of minocycline in 6-OHDA-induced toxicity in neuronal SH-SY5Y cells
|
Ossola, B.
|
|
2009
|
15 |
Supplement 4 |
p. S118-
1 p.
|
artikel
|
| 91 |
P1.219 Traditional Chinese medicine improves activities of daily living in Parkinson's disease
|
Weidong, P.
|
|
2009
|
15 |
Supplement 4 |
p. S85-
1 p.
|
artikel
|
| 92 |
P3.175 Transdermal lisuride is effective in Restless Legs Syndrome (RLS)
|
Beneŝs, H.
|
|
2009
|
15 |
Supplement 4 |
p. S193-
1 p.
|
artikel
|
| 93 |
P3.120 Uncontrolled neuroinflammation drives progressive neurodegeneration in Parkinson's disease
|
Gao, H.-M.
|
|
2009
|
15 |
Supplement 4 |
p. S179-
1 p.
|
artikel
|
| 94 |
P1.024 Verbal fluency and psychomotor speed in early Parkinson's disease: is there a link?
|
Hipp, G.
|
|
2009
|
15 |
Supplement 4 |
p. S35-
1 p.
|
artikel
|
| 95 |
P3.055 Welding fume-related dopaminergic neurotoxicity
|
Sriram, K.
|
|
2009
|
15 |
Supplement 4 |
p. S162-
1 p.
|
artikel
|
| 96 |
P1.185 Worry in Parkinson's disease: baseline data from the PROMS-PD cohort
|
Whitehead, D.
|
|
2009
|
15 |
Supplement 4 |
p. S76-
1 p.
|
artikel
|
| 97 |
Rodent models of treatment-induced motor complications in Parkinson's disease
|
Cenci, M. Angela
|
|
2009
|
15 |
Supplement 4 |
p. S13-S17
5 p.
|
artikel
|
| 98 |
Sleep dysfunction and role of dysautonomia in Parkinson's disease
|
Mitra, Tanya
|
|
2009
|
15 |
Supplement 4 |
p. S93-S95
3 p.
|
artikel
|
| 99 |
Sleepiness in Parkinson's disease
|
Arnulf, Isabelle
|
|
2009
|
15 |
Supplement 4 |
p. S101-S104
4 p.
|
artikel
|
| 100 |
Systematic review of the effect of dopamine receptor agonists on patient health-related quality of life
|
Martinez-Martin, Pablo
|
|
2009
|
15 |
Supplement 4 |
p. S58-S64
7 p.
|
artikel
|
| 101 |
The clinical progression of Parkinson's disease
|
Poewe, Werner
|
|
2009
|
15 |
Supplement 4 |
p. S28-S32
5 p.
|
artikel
|
| 102 |
The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: A pilot study
|
Tassorelli, Cristina
|
|
2009
|
15 |
Supplement 4 |
p. 675-681
7 p.
|
artikel
|
| 103 |
Toxic effects of dopamine metabolism in Parkinson's disease
|
Hattori, Nobutaka
|
|
2009
|
15 |
Supplement 4 |
p. S35-S38
4 p.
|
artikel
|
| 104 |
Treatment of dysautonomia associated with Parkinson's disease
|
Mostile, Giovanni
|
|
2009
|
15 |
Supplement 4 |
p. S224-S232
9 p.
|
artikel
|
Tijdschrift beschrijving